Definitive Healthcare (NASDAQ:DH) Issues Q4 2024 Earnings Guidance

Definitive Healthcare (NASDAQ:DH) updated its fourth quarter 2024 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 0.070-0.070 for the period, compared to the consensus estimate of 0.070. The company issued revenue guidance of $60.0 million-$61.0 million, compared to the consensus revenue estimate of $60.3 million. Definitive Healthcare also updated its FY 2024 guidance to 0.340-0.350 EPS.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on DH shares. Robert W. Baird reduced their price objective on Definitive Healthcare from $6.00 to $5.00 and set a “neutral” rating for the company in a research note on Wednesday, August 7th. Morgan Stanley decreased their price target on Definitive Healthcare from $9.00 to $5.00 and set an “equal weight” rating for the company in a report on Tuesday, August 6th. JPMorgan Chase & Co. cut shares of Definitive Healthcare from a “neutral” rating to an “underweight” rating and dropped their price objective for the stock from $7.00 to $5.00 in a research note on Wednesday, July 31st. BTIG Research assumed coverage on shares of Definitive Healthcare in a research note on Tuesday, September 17th. They issued a “buy” rating and a $7.00 target price for the company. Finally, Stifel Nicolaus lowered their price target on shares of Definitive Healthcare from $9.50 to $7.50 and set a “buy” rating on the stock in a report on Wednesday, July 31st. One analyst has rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, Definitive Healthcare currently has a consensus rating of “Hold” and an average target price of $5.81.

Definitive Healthcare Price Performance

NASDAQ DH traded up $0.01 on Thursday, hitting $4.31. The company had a trading volume of 543,720 shares, compared to its average volume of 748,693. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.40 and a quick ratio of 2.40. The company has a market capitalization of $508.28 million, a PE ratio of -1.24, a PEG ratio of 5.95 and a beta of 1.33. Definitive Healthcare has a 12-month low of $3.19 and a 12-month high of $10.62. The company’s fifty day moving average price is $4.38 and its 200-day moving average price is $5.04.

Definitive Healthcare (NASDAQ:DH) last released its quarterly earnings results on Monday, August 5th. The company reported $0.09 earnings per share for the quarter, hitting the consensus estimate of $0.09. Definitive Healthcare had a negative net margin of 156.65% and a positive return on equity of 0.98%. The firm had revenue of $63.70 million during the quarter, compared to the consensus estimate of $63.19 million. During the same quarter in the prior year, the firm earned $0.08 EPS. The company’s revenue for the quarter was up 4.4% on a year-over-year basis. As a group, analysts predict that Definitive Healthcare will post 0.07 earnings per share for the current year.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.